Our previous study showed that oral administration of EsB, a solanocapsine-type glycoside and a major component in tomato juice, ameliorated experimental dermatitis in mice through decreases in IgE and ConA-mitogenic action, and a decline in IL-4 secretion [14,15]. This evidence concerns the gene IGHE and skin disorder.